• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Jumps Over 100 Points; DNOW Posts Downbeat Earnings

    5/10/24 10:01:08 AM ET
    $DNOW
    $EVLV
    $GWAV
    $ITOS
    Oil and Gas Field Machinery
    Consumer Discretionary
    Computer peripheral equipment
    Technology
    Get the next $DNOW alert in real time by email

    U.S. stocks traded higher this morning, with the Dow Jones index jumping over 100 points on Friday.

    Following the market opening Friday, the Dow traded up 0.33% to 39,516.53 while the NASDAQ rose 0.43% to 16,416.55. The S&P 500 also rose, gaining, 0.38% to 5,233.70.

    Check This Out: Top 3 Industrials Stocks That May Collapse This Month

    Leading and Lagging Sectors

    Information technology shares rose by 1% on Friday.

    In trading on Friday, communication services shares fell by 0.2%.

    Top Headline

    DNOW Inc. (NYSE:DNOW) posted weaker-than-expected first-quarter financial results on Thursday.

    DNOW posted adjusted earnings of 21 cents per share, missing market estimates of 23 cents per share. The company's quarterly sales came in at $563.000 million, versus expectations of $569.150 million.

    Equities Trading UP
                           

    • Novavax, Inc. (NASDAQ:NVAX) shares shot up 128% to $10.18 after the company and Sanofi announced a co-exclusive licensing agreement to commercialize a COVID-19 vaccine and develop COVID-influenza combination vaccines.
    • Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) got a boost, surging 41% to $17.18 after the company announced a $120 million registered direct offering and reported Q1 financial results.
    • AEye, Inc. (NASDAQ:LIDR) shares were also up, gaining 45% to $1.70 after the company disclosed a partnership with LITEON Technology Corporation.

    Equities Trading DOWN

    • MacroGenics, Inc. (NASDAQ:MGNX) shares dropped 72% to $4.15 after the company reported worse-than-expected first-quarter financial results.
    • Shares of Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) were down 42% to $2.2250 after the company reported worse-than-expected first-quarter financial results and lowered its FY24 sales guidance below estimates.
    • Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) was down, falling 31% to $0.0480.

    Also Check This Out: How To Earn $500 A Month From Home Depot Stock Ahead Of Q1 Earnings

    Commodities

    In commodity news, oil traded up 0.8% to $79.88 while gold traded up 1.7% at $2,381.10.

    Silver traded up 1.8% to $28.87 on Friday, while copper rose 2.2% to $4.6850.

    Euro zone

    European shares were higher today. The eurozone's STOXX 600 rose 0.8%, Germany's DAX rose 0.5% and France's CAC 40 gained 0.7%. Spain's IBEX 35 Index rose 0.6%, while London's FTSE 100 rose 0.7%.

    Industrial production in Italy declined by 0.5% month-over-month in March compared to a revised flat reading in the prior month.

    The GDP in the UK expanded 0.4% month-over-month in March compared to revised 0.2% gain in February. UK’s trade deficit shrank to £1.098 billion in March versus a revised £1.478 billion in the previous month. Industrial production in the UK climbed 0.2% month-over-month during March.

    Asia Pacific Markets

    Asian markets closed higher on Friday, with Japan's Nikkei gaining 0.41%, China's Composite Index gaining 0.01%, Hong Kong's Hang Seng Index gaining 2.30% and India's S&P BSE Sensex gaining 0.36%.

    The gauge for Japan's service sector fell to 47.4 in April from 49.8 in the prior month, while value of loans in Japan rose 3.1% year-over-year in April. Japanese current account surplus widened to JPY 3,398.8 billion in March versus JPY 2,360.0 billion in the year-ago month.

    Economics

    Data on consumer sentiment will be released today.

    Now Read This: Insiders Buying PPG Industries And 2 Other Stocks

    Get the next $DNOW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DNOW
    $EVLV
    $GWAV
    $ITOS

    CompanyDatePrice TargetRatingAnalyst
    DNOW Inc.
    $DNOW
    11/21/2025$16.00Neutral → Positive
    Susquehanna
    Novavax Inc.
    $NVAX
    10/24/2025$18.00Overweight
    Cantor Fitzgerald
    MacroGenics Inc.
    $MGNX
    9/17/2025$3.00Overweight
    Barclays
    AEye Inc.
    $LIDR
    9/8/2025$6.00Buy
    Alliance Global Partners
    Novavax Inc.
    $NVAX
    8/28/2025$10.00Buy
    H.C. Wainwright
    Novavax Inc.
    $NVAX
    8/20/2025$7.00Neutral → Underperform
    BofA Securities
    Evolv Technologies Holdings Inc.
    $EVLV
    8/15/2025$9.00Hold → Buy
    Lake Street
    Evolv Technologies Holdings Inc.
    $EVLV
    8/15/2025$10.00Buy
    TD Cowen
    More analyst ratings

    $DNOW
    $EVLV
    $GWAV
    $ITOS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Jacobs John C covered exercise/tax liability with 39,132 shares and converted options into 83,197 shares, increasing direct ownership by 32% to 180,797 units (SEC Form 4)

    4 - NOVAVAX INC (0001000694) (Issuer)

    1/26/26 7:57:59 PM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Ellenbogen Michael sold $500,619 worth of shares (80,745 units at $6.20) and exercised 80,745 shares at a strike of $0.24 (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    1/20/26 4:20:01 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    President & CEO Kedzierski John converted options into 207,000 shares and sold $522,484 worth of shares (74,322 units at $7.03), increasing direct ownership by 1,658% to 140,678 units (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    1/6/26 4:09:10 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $DNOW
    $EVLV
    $GWAV
    $ITOS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    December 15, 2023 - FDA Roundup: December 15, 2023

    For Immediate Release: December 15, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA updated the breast implants web pages to share the latest information on: Risks and complications related to breast implants  Reports of squamous cell carcinoma (SCC), various lymphomas other than Breast Implants Associated Anaplastic Large

    12/15/23 3:14:20 PM ET
    $DNOW
    Oil and Gas Field Machinery
    Consumer Discretionary

    $DNOW
    $EVLV
    $GWAV
    $ITOS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Revenue Officer Marshall Robert E bought $42,420 worth of shares (7,000 units at $6.06) (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    11/25/25 4:03:38 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Director Charlton Kevin M. bought $85,196 worth of shares (15,000 units at $5.68) (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    11/21/25 4:39:17 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Director Shapiro Richard A bought $278,126 worth of shares (46,300 units at $6.01), increasing direct ownership by 133% to 52,515 units (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    11/20/25 4:20:48 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $DNOW
    $EVLV
    $GWAV
    $ITOS
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Novavax Inc.

    SCHEDULE 13G - NOVAVAX INC (0001000694) (Subject)

    2/9/26 7:56:48 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 10-Q filed by Greenwave Technology Solutions Inc.

    10-Q - Greenwave Technology Solutions, Inc. (0001589149) (Filer)

    2/5/26 3:56:09 PM ET
    $GWAV
    Metal Fabrications
    Industrials

    SEC Form SCHEDULE 13G filed by AEye Inc.

    SCHEDULE 13G - AEye, Inc. (0001818644) (Subject)

    1/30/26 1:42:49 PM ET
    $LIDR
    Auto Parts:O.E.M.
    Consumer Discretionary

    $DNOW
    $EVLV
    $GWAV
    $ITOS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FC Cincinnati Kicks Off 2026 with Addition of Evolv Express® Systems to TQL Stadium Entrances

    Evolv also becomes team and venue's "Official Fan Screening Partner" Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced it has completed a venue-wide installation of Evolv Express® at TQL Stadium in Cincinnati, Ohio. The stadium, which opened in 2021 and has a seating capacity of 26,000, is home to Major League Soccer's FC Cincinnati and has also hosted a wide range of international soccer matches, concerts, and other events. Known for its innovative design, TQL Stadium maintains an intimate feel, despite being one of the largest soccer-specific stadiums in North America

    2/5/26 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology to Present at TD Cowen Aerospace & Defense Conference

    Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced its scheduled participation in the TD Cowen Aerospace & Defense Conference on Wednesday, February 11, 2026 at 10:45 a.m. Eastern Time. Presenting on behalf of the Company will be Mr. Anil Chitkara, the Company's Co-Founder and Chief Growth Officer. Additional details including a link to the associated webcast will be available at the Company's investor relations website at https://ir.evolvtechnology.com. About Evolv Technology Evolv (NASDAQ:EVLV) is designed to transform human security by helping organizations det

    2/4/26 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    East Baton Rouge Parish Schools Triples its Evolv Express Gen2 Fleet, Strengthening Districtwide Security

    Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, announced today that Louisiana's East Baton Rouge Parish Schools is expanding its partnership with the company. The district, which initially deployed Evolv Express® weapons detection system last year, has added systems to eight more schools in the region. This expansion, in partnership with Alliance Technology Group, reflects the district's ongoing commitment to providing a secure and welcoming environment for its community. With this latest deployment, a total of twelve high schools are now operating Evolv's advanced security technolo

    2/3/26 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $DNOW
    $EVLV
    $GWAV
    $ITOS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DNOW Inc. upgraded by Susquehanna with a new price target

    Susquehanna upgraded DNOW Inc. from Neutral to Positive and set a new price target of $16.00

    11/21/25 8:04:46 AM ET
    $DNOW
    Oil and Gas Field Machinery
    Consumer Discretionary

    Cantor Fitzgerald resumed coverage on Novavax with a new price target

    Cantor Fitzgerald resumed coverage of Novavax with a rating of Overweight and set a new price target of $18.00

    10/24/25 8:05:21 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Barclays resumed coverage on MacroGenics with a new price target

    Barclays resumed coverage of MacroGenics with a rating of Overweight and set a new price target of $3.00

    9/17/25 8:02:48 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DNOW
    $EVLV
    $GWAV
    $ITOS
    Leadership Updates

    Live Leadership Updates

    View All

    TransAct Appoints Dana Loof as Chief Marketing Officer to Accelerate Growth and Platform Expansion

    TransAct Technologies Incorporated (NASDAQ:TACT) ("TransAct" or the "Company"), a global leader in software-driven technology and integrated printing solutions, today announced the appointment of Dana Loof as Chief Marketing Officer. Ms. Loof will lead TransAct's global marketing organization, with a mandate to strengthen brand leadership, sharpen go-to-market execution, and accelerate adoption of the Company's growing technology portfolio. Ms. Loof has a 30-year track record leading high-growth technology companies, where she has been responsible for global marketing strategy, brand strategy and positioning, category building, revenue generation, and customer engagement initiatives. In h

    1/20/26 4:05:00 PM ET
    $EVLV
    $TACT
    Computer peripheral equipment
    Technology

    Evolv Extends Partnership with New England Patriots, New England Revolution, and Gillette Stadium

    Extension of original 2021 agreement includes expansion of Evolv Express subscription, and official partnership designations Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced that it renewed its partnership with Gillette Stadium, home of the New England Patriots and New England Revolution. The renewal, which extends a partnership initiated in 2021, increases the number of entry points at which Evolv Express® security screening will be used. All members of the public entering the stadium for football games, soccer matches, concerts, and other events will pass through an

    9/16/25 12:00:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    MacroGenics Appoints Eric Risser as President and Chief Executive Officer

    ROCKVILLE, MD, Aug. 13, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company developing innovative antibody-based therapeutics for the treatment of cancer, today announced that effective as of August 13, 2025, Eric Risser has been appointed President, Chief Executive Officer and to the Board of Directors. Mr. Risser has served as Chief Operating Officer at MacroGenics since 2022, overseeing several key company functions and has led the Company's corporate development efforts, which have generated over $1.6 billion in non-dilutive capital since inception. Mr. Risser succeeds Scott Koenig, M.D., Ph.D. who is stepping down after serving as Presi

    8/13/25 4:01:00 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DNOW
    $EVLV
    $GWAV
    $ITOS
    Financials

    Live finance-specific insights

    View All

    Evolv Technology to Release Fourth Quarter Financial Results on March 10, 2026

    Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that the Company will release financial results for the fourth quarter of 2025 on Tuesday, March 10, 2026, after the market closes. Members of the Company's management team plan to host a live webcast at 4:30 p.m. Eastern Time on that day to discuss the financial results as well as management's outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com. About Evolv Technology Evolv (NASDAQ:EVLV) is designed to transform human security by helping organizations detect potential

    2/2/26 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology Reports Third Quarter Financial Results

    — Company Raises Revenue Outlook for 2025 to $142-$145 Million, up 37%-40% Year-Over-Year — Q3'25 Revenue of $42.9 million, up 57% year-over-year Q3'25 Ending ARR1 of $117.2 million, up 25% year-over-year Q3'25 Net Loss of $(1.8) million, with Net Profit Margin of (4)% Q3'25 Adjusted EBITDA2 of $5.1 million, with Adjusted EBITDA Margin2 of 12% Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter ended September 30, 2025. "We made meaningful progress across many key measures of the business in the third quarter—including

    11/13/25 4:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    AEye Reports Third Quarter 2025 Results

    Doubled customer base, fueling expansion across high-growth markets Secured strategic investment to significantly expand Apollo production capacity AEye, Inc. (NASDAQ:LIDR), a global leader in software-defined lidar solutions, and the manufacturer of the Apollo lidar sensor, today announced its results for the third quarter ended September 30, 2025. Recent Business Highlights Captured six new business wins since end of Q2, with 12 customer contracts signed year-to-date Secured strategic investment with leading global investor to expand Tier-1 manufacturing partnership and scale Apollo production to 60,000 units annually Delivered Apollo units to a global defense contractor powering

    11/6/25 4:05:00 PM ET
    $LIDR
    Auto Parts:O.E.M.
    Consumer Discretionary

    $DNOW
    $EVLV
    $GWAV
    $ITOS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

    SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    12/12/24 3:21:41 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    SEC Form SC 13G filed by Greenwave Technology Solutions Inc.

    SC 13G - Greenwave Technology Solutions, Inc. (0001589149) (Subject)

    12/5/24 10:00:25 AM ET
    $GWAV
    Metal Fabrications
    Industrials

    SEC Form SC 13G filed by iTeos Therapeutics Inc.

    SC 13G - iTeos Therapeutics, Inc. (0001808865) (Subject)

    11/21/24 8:27:38 PM ET
    $ITOS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care